A rapid microtitre plate screening method for in vitro assessment of fibrinolysis: A preliminary report

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 3, 2004, Pages 273-278

  Paul Brent, Peta Anne ^a   Cattley, Trudi N ^a   Myers, Stephen P ^a   Brooks, Lyndon ^a   Cheras, Phillip A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Fibrinolysis; Fibrinolytic drugs; Plasminogen activator inhibitor 1; Tissue type plasminogen activator

Indexed keywords

BETA GLOBULIN; FIBRIN; FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACCURACY; ADULT; ARTICLE; AUTOMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SCREENING; ENVIRONMENTAL TEMPERATURE; ENZYME ACTIVITY; ENZYME ASSAY; EUGLOBULIN LYSIS TEST; FEMALE; FIBRINOLYSIS; FOOD AND DRUG ADMINISTRATION; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; MALE; MICROTITER PLATE ASSAY; PLASMA; PRIORITY JOURNAL; REPRODUCIBILITY; SCREENING TEST; TEMPERATURE DEPENDENCE; VALIDATION PROCESS; VARIANCE;

ADULT; AUTOMATION; BLOOD COAGULATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; MALE; METHODS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SERUM GLOBULINS; STREPTOKINASE; TEMPERATURE;

EID: 2342423795     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200404000-00014     Document Type: Article

References (12)

1. Francis CW, Marder VJ. Physiological regulation and pathological disorders of fibrinolysis. Hum Pathol 1987; 18:263-274.
2. Blix S. Studies of the fibrinolytic system in the euglobulin fraction of human plasma. Scand J Clin Lab Invest Suppl 1961; 58:3-19.
3. Matsuda H, Samukawa K, Fukuda S, Shiomoto H, Tong CN, Kubo M. Studies of Panax japonicus fibrinolysis. Planta Med 1989; 55:18-21.
4. Jespersen J, Astrup T. A study of the fibrin assay of fibrinolytic agents. Optimal conditions, reproducibility and precision. Haemostasis 1983; 13:301-315.
5. Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 1952; 40:346-351.
6. Fossum S, Hoem NO. Urokinase and non-urokinase fibrinolytic activity in protease-inhibitor-deprived plasma, assayed by a fibrin micro-plate method. Immunopharmacology 1996; 32:119-121.
7. Drummond RK, Peppas NA. Fibrinolytic behaviour of streptokinase- immobilized poly(methacrylic acid-g-ethylene oxide). Biomaterials 1991; 12:356-360.
8. Cheras PA. The role of thrombosis in ischaemic of bone (INB) and primary arthritis (OA). Ph.D. thesis. Brisbane, Qld.: The University of Queensland; 1993.
9. Ranby M, Sundell IB, Nilsson TK. Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost 1989; 62:17-22.
10. Ranby M Norrman B, Wallen P. A sensitive assay for tissue plasminogen activator. Thromb Res 1982; 27:743-749.
11. Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31:427-436.
12. Biopharmaceutics Coordinating Committee. Guidance for 'industry - bioanalytical method validation. Rockville, Maryland: Center for Drug Evaluation and Research and Centre for Veterinary Medicine, Food and Drug Administration; 2001 Available from: http://www.fda.gov/cder/guidance/index.htm [accessed May 2003].